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Abstract
Background Abdominal aortic aneurysm (AAA) is an asymptomatic, potentially lethal condition predominantly
found in elderly. The mortality is 100 % if rupture occurs and left untreated, but even in treated patients the mortality
is substantial. Female sex and treatment with open repair rather than endovascular aortic repair (EVAR) have been
reported to negatively affect outcome. The objective was to describe the contemporary care and outcome of all
treated and untreated patients with ruptured AAA (rAAA) admitted to hospital.
Method Population-based retrospective investigation, including all patients admitted to the emergency departments
within Stockholm County diagnosed with rAAA 2009–2013. All identified patients’ charts (n = 297) were analyzed;
the study cohort includes 283 verified patients.
Results Men were in majority [214 (76 %), 69 (24 %) women] and were younger than women (78 vs 82 years,
p\ 0.001). A majority of patients were treated (212/283, 75 %), a similar proportion of women and men. Untreated
patients had a higher mean age (84 vs 77 years, p\ 0.001). The proportion treated with EVAR was 27 %, and they
were older than OR treated (79 vs 76 years, p = 0.043). Forty-seven percentage of patients admitted with rAAA
survived 30 days, and 62 % of treated patients survived 30 days. The 30-day mortality for women and men was
similar.
Conclusions Our results and other contemporary series show a shift toward a higher rate of treated patients with
rAAA, and improving outcomes, similar for women and men. The increased use of EVAR contributes to this
improvement in short-term outcome. High age influences the willingness to treat patients with rAAA.
Introduction
Abdominal aortic aneurysm (AAA) is an asymptomatic,
not uncommon and potentially lethal condition predomi-
nantly found in persons above 50 years of age. Patients
with ruptured AAA, left untreated, have a 100 % fatality
rate. The mortality is substantial even in treated patients
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with ruptured AAA (rAAA), ranging from 20 to 60 %
[1–3]. Interestingly, both AAA prevalence and the number
of patients treated for rAAA have declined the past
20 years; such a trend is reported in the Swedish national
registry parallel to an increment of elective repair (Fig. 1)
[1, 3, 4]. A further decline is expected due to the popula-
tion-based screening program for AAA in elderly men
introduced in our region [1, 3, 5–8].
Most studies have focused only on the treated patients,
and historically only a few studies have addressed and
included the persons admitted but left untreated, which
indeed does affect the view on patient care of this group
[2, 9–11]. Treated women, both in series of ruptured and
elective cases, have been reported to have a worse outcome
than men. This can correlate with their higher age when
treated, poorer morphology or different distribution of risk
factors [1, 12–16] A risk of withholding corrective treat-
ment in women with rupture compared to men has been
described: 73 % of men treated versus 56 % of women,
also confirmed in a single-center study from Australia
(fewer women were treated 37 vs 63 %) [17]. The strongest
predictor for death due to most surgical procedures, as well
as rAAA, is old age [1, 12, 18–22]. It is not certain how
influential the patient’s age is on the decision to offer
corrective treatment to rAAA patients. Mortality is higher
after OR than EVAR according to retrospective studies
[12, 21, 23, 24], and this is also reported in the Swedish
Vascular Registry [3]. EVAR is a less invasive method
than OR, with a lower perioperative complication rate, but
randomized trials have failed to show a difference in short-
term mortality [25–27].
The objective with this population-based investigation
was to report differences in the contemporary care of all
treated and untreated patients with rAAA admitted to a
hospital with special consideration of age and gender.
Materials and methods
Study population and settings
There are two centralized vascular departments serving the
county with emergency and elective vascular care:
Karolinska University Hospital and Stockholm South
General Hospital (So¨dersjukhuset), which together cover
20 % of the Swedish population, including care of patients
on the Island of Gotland. Patients operated outside of
Stockholm County were excluded from this analysis.
All patients admitted to the emergency departments of
the seven county hospitals within Stockholm County and
Island of Gotland, and diagnosed with rAAA according to
revision 10 of the International Classification of Diseases
(ICD 10: I71.3) from January 2009 to December 2013 were
identified. All hospitals have electronic daily updated
chart systems, and the healthcare system is based on a
delivery of the patients’ care (date for hospital stay, diag-
nosis, operations and the unique personal number of each
inhabitant) which will then allow reimbursement to the
hospital accordingly. This financial hospital system mini-
mizes events of care that are unregistered. Surgery, medi-
cine, cardiology and emergency departments were included
in the requisition, to minimize missing rAAA patients
admitted at other departments.
Data collection
All identified patients admitted to the hospitals were
identified by their unique personal identity numbers at each
hospital (n = 297). Twelve patients were excluded;
because of previous aortic surgery (n = 10) and mycotic
rAAA (n = 2). Two patients could not be identified due to
invalid personal registration numbers.
Definitions
AAA was defined as an aneurysm with an infra-renal
proximal limit. rAAA was verified as the diagnosis men-
tioned explicitly in medical records, with typical rupture
verified by radiology or at intervention, or in an autopsy
report. Hospital stay and ICU stay were calculated from
date of admittance and date of discharge. AAA diameter
was defined as the largest diameter of the ruptured aneur-
ysm on CT or ultrasound. Type of surgery was defined as
either OR or EVAR. The group definition ‘‘Cardiac dis-
ease’’ includes: former or current heart failure, angina
pectoris, myocardial infarction or arrhythmia mentioned in
medical records. Smoking was defined as past or current
smoking, from medical records. Preoperative mortality was
defined as death before start of operation. Perioperative
Fig. 1 Annual number of elective and ruptured patients treated in
Sweden 2005–2013, from SWEDVASC, changes in the Web-based
program was performed in 2008, which influences the number of all
registered cases
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mortality was defined as death during operation, including
anesthesia. 30-day mortality included perioperative and
postoperative death within 30 days after surgery. There
were some missing values, such as smoking habits, which
contribute to lower numbers in the presented tables. Height
and weight were used to calculate body mass index (BMI).
Statistics
Continuous variables, with a normal distribution (age,
AAA diameter and anthropometrical variables), are pre-
sented as mean ± standard deviation (SD). Normal distri-
bution of continuous variables was tested according to
Fig. 2 All admitted patients
with rAAA, and mortality
within 30 days for all women
and men during 2009–2013. Red
boxes show surviving patients,
gray boxes show the deceased.
*percent of treated cohort,
n = 212






Age (years) 77.56 ± 9.26 82.14 ± 6.57 \0.001
BMIb 28.4 (16.8) 22.4 (2.9) 0.002
AAA diameter (mm)d 82.7 ± 20.23 73.6 ± 15.98 0.006
Previously known AAA 58 (27.1) 27 (39.1) 0.058
Hypertension 126 (58.9) 49 (71.6) 0.19
Diabetes mellitus 27 (12.6) 8 (11.6) 0.961
COPD 27(.12.6) 15 (21.7) 0.18
Cardiac disease 81 (37.9) 21 (30.4) 0.475
Ever smokera 82/110 (74.5) 24/34 (70.6) 0.752
Pre-op creatininec 121.4 (51.4) 107.8 (42.4) 0.089
Operation rate 162 (75.7) 50 (72.4) 0.625
ICU stay all (days) 4.38 (7.77) 3.27 (6.05) 0.287
30-Day mortality all admitted 114 (53) 37 (54) 0.756
Treated 162 men 50 women
Mean age 75.7 (8.68) 80.7 (6.15) \0.001
EVAR rate (% of operated) 41 (25.3) 17 (34.0) 0.511
Hospital stay (days) for treated 13.7 (18.2) 11.3 (10.5) 0.245
ICU stay (days) 5.80 (8.52) 4.57 (6.05) 0.278
Perioperative mortality 14 (8.9) 5 (10.4) 0.815
30-Day mortality all treated 62 (38) 18 (36) 0.860
Presented as numbers (%) and mean (standard deviation)
a Missing cases: 35 women and 104 men, classified as unknown smoking history, bkg/m 2, cmicromol/l
d According to primary assessment by radiologist (134 missing assessments)
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Shapiro–Wilk’s, where p[ 0.05 indicates normality;
independent t test was used for continuous variables. Cat-
egorical values were presented as absolute numbers and
percentages. Pearson’s Chi-square test was used for cate-
gorical variables. SPSS version 22 (IBM, Armonk, New
York, US) was used for statistical analysis and calculation.
Level of significance was set at p B 0.05.
Ethical permission and reporting
The study was approved by the Regional Ethical Review
Board in Stockholm. Registration number: 2013/1277-31/
3. The reporting of this study conforms to the Strength-
ening the Reporting of Observational Studies in Epidemi-
ology (STROBE) statement [28].
Results
Patient characteristics
The study cohort is based on 283 patients diagnosed with
rAAA, 214 (76 %) men and 69 (24 %) women (Fig. 2;
Table 1). Women were older (82 vs 78 years, p\ 0.001)
compared to men (Table 1). The distribution between the age
groups was different for women and men, and a majority of
women were older than 80 as compared to men (69 vs 48 %,
p = 0.005). The youngest woman was 67 years, the youngest
man was 48, and 20 men were admitted with rAAA below
65 years of age (9 % of all men). Men had higher body mass
index and creatinine clearance as compared to women; most
other comorbid conditions were similar. The ICU stay for
patients admitted after treatment was similar for women and
men, and the mean stay was 4 days (Table 1).
Mortality rates (preoperative, perioperative, postopera-
tive) were similar in men and women, even though women
were 4.5 years older (Table 1). Overall, 47 % of patients
admitted to hospital with rAAA will survive 30 days, and
62 % of patients subjected to treatment will survive
30 days (Table 1; Fig. 2).
Treatment and outcome
Treated
The intervention rates were similar in women and men (72 vs
76 %, p = 0.625; Table 1). The treated women had a higher
mean age than treated men (Table 1). Among the treated













Fig. 3 Annual number of untreated and treated patients, and the
number of treated patients with EVAR or OR 2009–2013






Mean age (SD) 76.2 (7.96) 78.8 (9.34) 0.043
Previously detected 36 (23) 14 (24) 0.907
Women 33 (21) 17 (29) 0.223
Hypertension 99 (64) 34 (59) 0.45
Heart disease 52 (34) 20 (34) 0.63
COPD 18 (12) 13 (22) 0.117
Creatinine 115.4 (44.0) 126.5 (63.3) 0.26
Blood pressure, lowest beforea 74.12 (41.1) 96.30 (39.1) \0.001
ICU stay (days) 6.3 (8.81) 3.49 (4.93) 0.006
Hospital stay 14.3 (18.6) 10.1 (9.67) 0.036
Perioperative mortality 18 (11.7) 1 (1.7) 0.024
30-Day mortality all treated 72 (46.8) 8 (13.8) 0.001
Presented as numbers (%) and mean (standard deviation)
a Missing cases: 30 patients
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cardiac disease than women [61/162 (38 %) vs 11/50 (22 %)
in women,p = 0.07]. Diabetes, hypertension and COPD were
similarly distributed (data not shown).
The proportion of patients treated with EVAR was
27 %, similar for women and men (34 vs 25 %, p = 0.51;
Table 1). The use of EVAR increased during the later
observed time period (Fig. 3). The EVAR-treated patients
were older than OR-treated patients (79 vs 76 years,
p = 0.043; Table 2). The comorbidity profile was similar
between the groups (Table 2). The lowest preoperative
systolic BP was found in the OR group.
The postoperative care was prolonged in OR patients
(longer ICU, hospital stay), and they had a higher periop-
erative and 30-day mortality than EVAR treated (Table 2).
The 30-day mortality for treated women and men was
similar (13/50 vs 48/162, 29 %, p = 0.961; Table 1).
Untreated
A majority of patients admitted to the ER with rAAA were
treated (212/283, 75 %). The mortality among patients who
were not operated was 100 %. The untreated patients had a
higher mean age than treated [84 (SD 8.20) vs 77 (SD 8.42)
years, p\ 0.001; Table 3]. There was a similar proportion
of men and women in the untreated group (p = 0.63;
Table 1; Fig. 2). A higher proportion of the untreated
patients had a previously diagnosed AAA (35/71 vs
50/212, p\ 0.001). The age difference between women
and men is smaller in the untreated group compared to the
treated (85.8 vs 83.2 years for untreated and 80.7 vs
75.7 years in treated, p\ 0.001).
Discussion
This contemporary series on rAAA patients shows that
75 % of rAAA patients admitted to a hospital are treated,
and the survival rate among the treated patients is better
than reported in older series. There is also a lack of gender
differences in crude operation rates or outcome when
analyzing all patients admitted with rAAA, although
women were considerably older than men. Several recent
publications have reported on similar rates of untreated as
ours, 25 % and also a lack of gender differences. A better
immediate outcome is found in patients treated with EVAR
rather than OR.
Few series have historically included the untreated
group; however, several recently published series have
included them [2, 9, 10, 23]. The report from the UK on
rAAA has a similar proportion as Stockholm, 26 % [2].
The recently published Finnish study based on data from
2001 to 2011 report 57 % untreated, however, includes
persons dying at home, before treatment is evaluated.
Including only the patients admitted to hospital were
included, their rate would be similar to ours (25 %, 70/281)
[10] (Table 4). The recently published report on patients
collected during 8 years, in the Netherlands on ‘‘treated
versus untreated,’’ is difficult to interpret and has a parallel
ongoing bias for inclusion into the Ajax trial [11]. The
Norwegian study covering 2000–2013, on 216 patients, has
quite similar data [9] (Table 4). The older, often cited
autopsy-based report from Malmo¨ had a higher rate of
untreated [29]. Probably, we have a shift in the care of
rAAA and AAA patients, and a more positive attitude
toward treating more diseased patients. The better imme-
diate results of EVAR versus OR could also contribute
[18, 23, 30].
Age has always been reported to be an influential factor
when outcome is evaluated in surgical series
[1, 22, 27, 31, 32]. It is clear that the number of aged
patients is high among the untreated in this and other ser-
ies. In our study, the difference in mean age in untreated
and treated was 5 years, which is in the range of 3–6 years
found in previous studies [1, 12, 13, 16]. In our study, the
age difference between men and women who were
untreated was only 2 years, compared to the 5-year age
Table 3 Preoperative characteristics for treated and untreated, treatment and outcome variables for all included patients
Variable Untreated
N = 71(25 %)
Treated
N = 212(75 %)
p
Mean age (SD) years 83.9 (8.20) 76.9 (8.42) \0.001
Women 19 (27) 52 (25) 0.634
Previously detected 35 (49) 50 (24) \0.001
Hypertension 42 (59) 133 (63) 0.818
Heart disease 30 (42) 72 (34) 0.444
Diabetes 5 (7) 30 (14) 0.276
COPD 11 (15) 31 (15) 0.967
Blood pressure, lowest registereda 67.87 (45.51) 80.58 (41.68) 0.074
Presented as numbers (%) and mean (standard deviation)
a Missing cases, in analysis; 19 untreated and 30 treated
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difference in treated, which implies that age is an important
factor when the decision to operate or not is made, more
than gender.
During the study period, a shift in the care of patients
was performed in the County, and an ‘‘EVAR first strat-
egy’’ was developed, which have been reported by others
[2–4, 23, 27]. This started in 2010–2011, and specific
analysis has therefore not been analyzed in detail. The
operation rates for AAA overall have increased for both
men and women since the 1970s [1, 3, 13, 16]. During the
period from 1971 to 1986, operation rates were reported to
be 28 % for women and 56 % for men [29]. Population-
based retrospective studies have showed that a lower pro-
portion of women than men with rAAA are operated
[13, 16]. The operation rate for women in our study is,
however, high and corresponds well to other contemporary
reports (Reite 22 %, Dalman 26 %) [9, 23]. This indicates
a shift in the care of rAAA patients and will also increase
the mean age in treated (Fig. 3). One can suspect that the
increasing number of screened men (which started in the
fall 2010) will affect the proportion of treated women with
rupture, since the number of men with rupture will
decrease in the future [8, 33]. The screening program has
not yet affected the rupture rate in the general population in
our region, so findings from this report should still be
applicable to populations without general screening.
The number of elderly patients treated with EVAR is
clearly shown in this material, which confirms other
reports, both registry based and single centers. The case
mix makes all comparisons on outcome difficult between
OR and EVAR patients; the EVAR-treated patients are
older, but obviously have a different morphology with
smaller aneurysms, and require less ICU and hospital stay,
as has been shown by others [12, 21, 23].
The Swedvasc annual report 2014 showed that the total
proportion of rAAA operations conducted with EVAR in
Sweden was 39 % in 2013 [3]. In our study, the total rate of
EVAR among operated patients (men and women) during
the 5-year period was 27 %, with more performed in the
latter period. The largest randomized trial comparing
EVAR first strategy versus OR first for rAAA found that
women have greater survival benefit from EVAR relatively
to OR than men [26].
The outcome in a rAAA must always include reflec-
tions upon the number of treated versus untreated, since a
high intervention rate will give a poorer survival rate and
a lower intervention rate gives a better survival rate due
to the selection bias. This is difficult to control, and mean
age is a possible surrogate variable for such a biased
inclusion. Our study includes all patients with rAAA
admitted to hospital, but does not tell us about the number
of deaths from rAAA outside of hospital. The in-hospital
mortality from rAAA has declined since the 1980s, partly
due to the introduction of EVAR [1, 16, 30], but there is
no reason to believe that the mortality from rAAA outside
of hospital has declined. Bengtsson et al. [29] performed
a retrospective study in Malmo¨, including operated
patients who died in hospital and outside of hospital
(autopsy rate 85 %). Their poorer outcome compared to
reported contemporary data from us and others could
reflect a higher awareness today when referring rAAA
patients, increased willingness to treat even old patients
with comorbidity and possibly the increased use of EVAR
(Table 4).
Postoperative mortality has been reported to be higher
for women than for men in several previous studies, even if
contradictory findings have been reported after age
adjustments [5, 12, 13, 16, 21, 31]. In our study, and others,
30-day crude mortality was almost identical between all
men and women regardless of the age difference
[9, 14, 31]. The reasons mentioned above are probably
highly applicable for both women and men.
Table 4 Previous publications on numbers and outcome for untreated and treated patients admitted with rAAA
Author Time period Number of patients
admitted
Untreated Mortality all Mortality treated
Bengtsson et al.
(1971–1986)
125 51 % 79 % (30 days) 57 %
McPhee (2001–2004) 37,016 32 % (41 % women vs 30 %
men)
Not reported 37 % (43 % women vs 36 %
men)b
Ozdemir (2005–2010) 9877 42 % 67.5 %
(90 days)
44 % (90 days)
Va¨nnia (2001–2011) 354 26 % (134 nonadmitted) 71 % 43 % treated
Reite (2000–2013) 196 (216) 26 % 64 % (30 days) 51 % (90 days)
Hultgren (2009–2013) 280 25 % 53 % (30 days) 38 % (30 days)
a 134 died outside hospital (27 %)
b In-hospital
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Strengths and limitations
The included patients in this study represent a fifth of all
admitted persons with rAAA in Sweden. In an international
comparison, this is a large material for this type of study,
considering the study period. As all retrospective studies,
this study has its limitations as we rely on information
partly collected in an acute care setting without research
purposes, resulting in missing data. The results do har-
monize well with other recent reports.
Causes of death
In Stockholm County, approximately 15,500 persons die
annually (15–18 % of the total death rate in Sweden), and
the death rate in Sweden is 87,000–90,000 annually. The
autopsy rate in Sweden was only 11 % in 2013, and in
elderly women 6 %, the reliability of reported Causes of
Deaths is therefore questionable [33]. A further extraction
of reported deceased persons registered as rAAA at home,
from central registries, would probably therefore not bring
substantial information.
Conclusions
Our results and other contemporary series show a shift toward
a higher rate of treated persons with rAAA, and improving
outcomes for this patient group. The influence of EVAR as a
‘‘first-line’’ treatment modality does contribute to the
improved outcome. In contrast to our hypothesis, female sex
does not influence the treatment rates or outcome for rAAA
patients, rather age is a factor that influences the willingness to
treat patients with rAAA. Further analysis of radiological
findings and postoperative complications to explain the pos-
itive transition in the care of this patient group are called for.
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